Chapter 1 Hemophilia Gene Therapy Market Overview
1.1 Hemophilia Gene Therapy Definition
1.2 Global Hemophilia Gene Therapy Market Size Status and Outlook (2018-2032)
1.3 Global Hemophilia Gene Therapy Market Size Comparison by Region (2018-2032)
1.4 Global Hemophilia Gene Therapy Market Size Comparison by Type (2018-2032)
1.5 Global Hemophilia Gene Therapy Market Size Comparison by Application (2018-2032)
1.6 Global Hemophilia Gene Therapy Market Size Comparison by Sales Channel (2018-2032)
1.7 Hemophilia Gene Therapy Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in Hemophilia Gene Therapy Market
Chapter 2 Hemophilia Gene Therapy Market Competition by Player
2.1 Global Hemophilia Gene Therapy Sales and Market Share by Player (2021-2023)
2.2 Global Hemophilia Gene Therapy Revenue and Market Share by Player (2021-2023)
2.3 Global Hemophilia Gene Therapy Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Hemophilia Gene Therapy Market Segment by Type
3.1 Global Hemophilia Gene Therapy Market by Type
3.1.1 Hemophilia A Gene Therapy
3.1.2 Hemophilia B Gene Therapy
3.1.3 Others
3.2 Global Hemophilia Gene Therapy Sales and Market Share by Type (2018-2023)
3.3 Global Hemophilia Gene Therapy Revenue and Market Share by Type (2018-2023)
3.4 Global Hemophilia Gene Therapy Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 Hemophilia Gene Therapy Market Segment by Application
4.1 Global Hemophilia Gene Therapy Market by Application
4.1.1 Hospital
4.1.2 Non-Hospital
4.2 Global Hemophilia Gene Therapy Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 Hemophilia Gene Therapy Market Segment by Sales Channel
5.1 Global Hemophilia Gene Therapy Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Hemophilia Gene Therapy Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 Hemophilia Gene Therapy Market Segment by Region & Country
6.1 Global Hemophilia Gene Therapy Market Size and CAGR by Region (2018-2032)
6.2 Global Hemophilia Gene Therapy Sales and Market Share by Region (2018-2023)
6.3 Global Hemophilia Gene Therapy Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Hemophilia Gene Therapy Market Share by Type
6.4.3 North America Hemophilia Gene Therapy Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Hemophilia Gene Therapy Market Share by Type
6.5.3 Europe Hemophilia Gene Therapy Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Hemophilia Gene Therapy Market Share by Type
6.6.3 Asia-Pacific Hemophilia Gene Therapy Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Hemophilia Gene Therapy Market Share by Type
6.7.3 South America Hemophilia Gene Therapy Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Hemophilia Gene Therapy Market Share by Type
6.8.3 Middle East & Africa Hemophilia Gene Therapy Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Hemophilia Gene Therapy Players
7.1 Spark Therapeutics
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Ultragenyx
7.3 Shire PLC
7.4 Sangamo Therapeutics
7.5 Bioverativ
7.6 BioMarin
7.7 uniQure (CSL Behring)
7.8 Freeline Therapeutics
7.9 Pfizer
7.10 Novo Nordisk
Chapter 8 Upstream and Downstream Analysis of Hemophilia Gene Therapy
8.1 Industrial Chain of Hemophilia Gene Therapy
8.2 Upstream of Hemophilia Gene Therapy
8.3 Downstream of Hemophilia Gene Therapy
Chapter 9 Development Trend of Hemophilia Gene Therapy (2024-2032)
9.1 Global Hemophilia Gene Therapy Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global Hemophilia Gene Therapy Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
